Biodesix Inc SEC filings BDSX
Biodesix Inc has 600 filings in SEC EDGAR's recent list, going back to Jul 8, 2008. Its latest annual report, Form ARS, was filed on Apr 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Jun 1, 2026 | — |
| S-3 | Shelf registration | May 21, 2026 | — |
| S-8 | Employee stock plan registration | Feb 6, 2026 | — |
| S-8 | Employee stock plan registration | May 30, 2025 | — |
| S-8 | Employee stock plan registration | Feb 7, 2025 | — |
| 424B3 | Prospectus | Nov 12, 2024 | — |
| 424B5 | Prospectus supplement | Nov 12, 2024 | — |
| S-3 | Shelf registration | Nov 1, 2024 | — |
| S-3 | Shelf registration | Nov 1, 2024 | — |
| 424B5 | Prospectus supplement | Aug 7, 2024 | — |
| 424B3 | Prospectus | Jun 5, 2024 | — |
| S-1/A | Amended registration statement | May 24, 2024 | — |
| S-1 | Registration statement | Apr 23, 2024 | — |
| 424B5 | Prospectus supplement | Apr 5, 2024 | — |
| 424B5 | Prospectus supplement | Apr 5, 2024 | — |
| S-8 | Employee stock plan registration | Feb 2, 2024 | — |
| S-8 | Employee stock plan registration | Feb 2, 2023 | — |
| 424B5 | Prospectus supplement | Nov 18, 2022 | — |
| 424B5 | Prospectus supplement | Nov 16, 2022 | — |
| S-3 | Shelf registration | Jun 6, 2022 | — |
| S-8 | Employee stock plan registration | Jun 6, 2022 | — |
| 424B5 | Prospectus supplement | Mar 7, 2022 | — |
| 424B5 | Prospectus supplement | Dec 22, 2021 | — |
| S-3/A | Filing | Nov 24, 2021 | — |
| S-3 | Shelf registration | Nov 16, 2021 | — |
| S-8 | Employee stock plan registration | Nov 2, 2020 | — |
| 424B4 | Prospectus | Oct 29, 2020 | — |
| S-1/A | Amended registration statement | Oct 26, 2020 | — |
| S-1/A | Amended registration statement | Oct 21, 2020 | — |
| S-1/A | Amended registration statement | Oct 14, 2020 | — |
| S-1/A | Amended registration statement | Oct 9, 2020 | — |
| S-1 | Registration statement | Oct 2, 2020 | — |
Showing 32 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- BDSX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Louisville, CO
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1439725
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.